Eliquis 5 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F9DYX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,763
Award facts
- Contract value 100% obligated
- $19,763.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a competitive delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 29, 2026, for the supply of Eliquis 5 mg tablets (60-count units) with a firm fixed-price ceiling value of $19,763.41. The delivery order is scheduled for completion by January 30, 2026, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This award carries no set-aside designation and was competitively awarded through the open contracting process. The order represents a task order under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical supply vehicle for military healthcare systems worldwide.
Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as Amerisourcebergen), is a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, and serves as a critical vendor for federal medical procurement. The company's federal contract portfolio demonstrates extensive capability in supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military treatment facilities and veterans' healthcare programs. The Eliquis delivery exemplifies the company's role in supplying essential prescription medications through its established relationship with DLA's Medical Supply Chain for global pharmaceutical support operations.
Quick answers
Who was awarded contract SPE2DR26F9DYX?
SPE2DR26F9DYX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F9DYX worth?
The government has obligated $19,763 on SPE2DR26F9DYX.
Is contract SPE2DR26F9DYX an order under another contract?
Yes. SPE2DR26F9DYX is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9DYX competed?
The extent of competition for SPE2DR26F9DYX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award